FR2394297A1 - Particules de dane de l'hepatite b - Google Patents

Particules de dane de l'hepatite b

Info

Publication number
FR2394297A1
FR2394297A1 FR7732653A FR7732653A FR2394297A1 FR 2394297 A1 FR2394297 A1 FR 2394297A1 FR 7732653 A FR7732653 A FR 7732653A FR 7732653 A FR7732653 A FR 7732653A FR 2394297 A1 FR2394297 A1 FR 2394297A1
Authority
FR
France
Prior art keywords
dane particles
hepatitis
dane
particles
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7732653A
Other languages
English (en)
French (fr)
Other versions
FR2394297B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
William J Mcaleer
Edward H Wasmuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/784,191 external-priority patent/US4129646A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2394297A1 publication Critical patent/FR2394297A1/fr
Application granted granted Critical
Publication of FR2394297B1 publication Critical patent/FR2394297B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D43/00—Separating particles from liquids, or liquids from solids, otherwise than by sedimentation or filtration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7732653A 1976-11-02 1977-10-28 Particules de dane de l'hepatite b Granted FR2394297A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73786276A 1976-11-02 1976-11-02
US05/784,191 US4129646A (en) 1976-11-02 1977-04-04 Isolating hepatitis B Dane particles

Publications (2)

Publication Number Publication Date
FR2394297A1 true FR2394297A1 (fr) 1979-01-12
FR2394297B1 FR2394297B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-11-19

Family

ID=27113269

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7732653A Granted FR2394297A1 (fr) 1976-11-02 1977-10-28 Particules de dane de l'hepatite b
FR7910456A Granted FR2422406A1 (fr) 1976-11-02 1979-04-25 Composition comprenant un concentrat de particules de dane
FR7910455A Granted FR2422399A1 (fr) 1976-11-02 1979-04-25 Procede pour la concentration de particules de dane par fractionnement isopycnique

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR7910456A Granted FR2422406A1 (fr) 1976-11-02 1979-04-25 Composition comprenant un concentrat de particules de dane
FR7910455A Granted FR2422399A1 (fr) 1976-11-02 1979-04-25 Procede pour la concentration de particules de dane par fractionnement isopycnique

Country Status (5)

Country Link
JP (1) JPS5379011A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2748520A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (3) FR2394297A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB1554400A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7711378A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008826A3 (en) * 1978-08-18 1980-09-03 Metrofoss K/S Method and apparatus for counting bacteria in a bacteria-containing suspension, method for fluorescence staining of bacteria, and method for separating bacteria from a sample
FR2561256A1 (fr) * 1984-03-16 1985-09-20 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
DE3049690A1 (de) * 1979-07-05 1982-02-18 Alpha Therapeutic Corp Process for producing hepatitis b vaccine
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
EP0114291A3 (de) * 1983-01-24 1985-12-04 Bodo Dr. Plewinsky Mittel zur Trennung gelöster und/oder ungelöster Stoffe aufgrund unterschiedlicher Auftriebsdichten bzw. Dichten vermittels der Lösungen echter Metawolframate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2152800A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-09-09 1973-04-27 Pfizer
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
FR2382238A1 (fr) * 1977-02-23 1978-09-29 Merck & Co Inc Procede de purification de l'antigene de l'hepatite b, et produits obtenus
FR2412315A1 (fr) * 1977-02-23 1979-07-20 Merck & Co Inc Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2152800A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-09-09 1973-04-27 Pfizer
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
FR2382238A1 (fr) * 1977-02-23 1978-09-29 Merck & Co Inc Procede de purification de l'antigene de l'hepatite b, et produits obtenus
FR2412315A1 (fr) * 1977-02-23 1979-07-20 Merck & Co Inc Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008826A3 (en) * 1978-08-18 1980-09-03 Metrofoss K/S Method and apparatus for counting bacteria in a bacteria-containing suspension, method for fluorescence staining of bacteria, and method for separating bacteria from a sample
FR2561256A1 (fr) * 1984-03-16 1985-09-20 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite

Also Published As

Publication number Publication date
FR2422406B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-11-19
FR2422399B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-11-19
FR2422406A1 (fr) 1979-11-09
GB1554399A (en) 1979-10-17
NL7711378A (nl) 1978-05-05
DE2748520C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-07-30
JPS635381B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-02-03
GB1554400A (en) 1979-10-17
DE2748520A1 (de) 1978-05-03
JPS5379011A (en) 1978-07-13
FR2394297B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-11-19
FR2422399A1 (fr) 1979-11-09

Similar Documents

Publication Publication Date Title
GR3030595T3 (en) Platelet activating factor antagonists.
OA05938A (fr) Procédé de fabrication d'un concentré protéique contenant des facteurs immunologiques d'origine lactique.
ES8206856A1 (es) Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica
OA08801A (fr) Antigènes de surface du virus de l'hépatite B et antigènes hybrides les contenant.
DE3275506D1 (en) Magnetic flotation
ATA391682A (de) Verfahren zur herstellung eines monoklonalen antikoerpers gegen tumos-assoziiertes antigen und dessen verwendung
FR2394297A1 (fr) Particules de dane de l'hepatite b
AT380645B (de) Verfahren zur abscheidung von sauren schadgasen und verbrennungsanlage zur durchfuehrung des verfahrens
ATE145246T1 (de) Monoklonale antikörper zur induzierung von toleranz
GB2083836A (en) Monoclonal antibody
BE879230A (fr) Filtre pour l'epuration d'un fluide contenant des particules ferro-magnetiques
ATE87941T1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
FR2514028B1 (fr) Procede de chloruration selective de melanges d'oxydes metalliques d'origine naturelle ou synthetique
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE146596T1 (de) Diagnostisches verfahren und reagenz für hiv
BE889835A (fr) Appareil pour separer les constituants d'un melange de sable et de particules fines d'origine botanique
EP0185391A3 (en) Method for the purification of the hbc antigen and method for the measurement of hbc antibodies by using said purified hbc antigen
DE2964390D1 (en) Isolation of hepatitis be antigen
DE3783838D1 (de) Reagenz und verfahren zum klassifizieren von leukozyten durch durchfluss-zytometrie.
Suzuki et al. Idiotypic and fine specificity analysis of a (4‐hydroxy‐3‐nitrophenyl) acetyl (NP)‐specific suppressor T cell hybridoma at the level of cell surface structures, isolated receptor material and functional suppressor factor
EP0313986A3 (en) Immunoassays using antigens produced in heterologous organisms
FR2470795A1 (fr) Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
SE8404538D0 (sv) Forfaringsteknik med polypropylenglykol for rorelse och blandning av blod med annan vetska i ett kapillerror
BE878690A (fr) Dispositif en vue de fixer des injecteurs des ajutages ou des tubulures d'admission ainsi qu'en vue d'etancheifier des sacs filtrants dans les fonds tubulaires souples des filtres pour gaz charges de poussieres
FR2550203B1 (fr) Peptides synthetiques immunogenes porteurs d'un epitope caracteristique de l'antigene de surface du virus de l'hepatite b et compositions les contenant

Legal Events

Date Code Title Description
ST Notification of lapse